Search for: "Endo Pharmaceuticals Inc."
Results 81 - 100
of 136
Sorted by Relevance
|
Sort by Date
2 May 2014, 10:23 am
Despite Auxilium Pharmaceuticals’ opposition, a joint response filed on behalf of other testosterone drug manufactures such as Abb Vie, Inc., Abbott Laboratories, Eli Lilly and Co., Lilly USA, LLC, and Endo Pharmaceuticals, Inc. indicates support for the centralization of all pending testosterone replacement therapy lawsuits before the same judge. [read post]
25 Jul 2012, 7:36 am
The lawsuit against Bard is just one in hundreds now being brought against makers of transvaginal mesh, including Bard, J&J, Boston Scientific Corp. and American Medical Systems of Endo Pharmaceutical Holdings Inc. [read post]
18 Mar 2010, 2:30 am
(Patent Docs) Opana (Oxymorphone) - US: District Court New Jersey: Patent infringement complaint following a Paragraph IV Certification: Endo Pharmaceuticals Inc. et al. v. [read post]
16 Feb 2018, 2:06 pm
Also named in the lawsuit were Allergan, Cephalon, Teva Pharmaceuticals, Endo Health Solutions and Endo Pharmaceuticals, Janssen Pharmaceuticals, Johnson & Johnson and Purdue Frederick Co. [read post]
27 Apr 2010, 10:58 pm
Solstice International Partners et al (Docket Report) US: FTC annual report highlights the Commission’s patent settlement efforts (FDA Law Blog) Products Adcirca (Tadalafil) – US: Declaratory judgement of non-infringement and invalidity based on ANDA to manufacture generic Adcirca: Synthon v Eli Lilly et al (Patent Docs) Amrix (Cyclobenzaprine) – US: Mylan seeks declaratory judgment of noninfringement, unenforceability and invalidity of Amrix patent, based on Mylan’s… [read post]
8 Oct 2009, 6:05 am
Reddy’s, Barr and Purepac (Patent Baristas) Renagel (Sevelamer) – US: Genzyme files patent infringement suit against Endo Pharmaceuticals following Para IV challenge (Patent Docs) Roundup Ready cotton seed – US: Monsanto files patent infringement suits against Brent M Hargrove and Larry H Lytle based on defendants’ use of cotton seed produced from earlier planted Roundup Ready cotton seed (Patent Docs) Seroquel (Quetiapine) – US:… [read post]
25 Oct 2008, 12:03 am
Sandoz, Inc (Law360) (Hal Wegner) (Patently-O) (Patent Prospector) (PLI) Cipro (Ciprofloxacin) - US: CAFC finds no antitrust liability for Hatch-Waxman reverse payment settlements: In Re Ciproflaxacin Hydrochloride Antitrust Litigation (IP Law Observer) Lescol (Fluvastatin) - US: Mylan confirms first-to-file patent challenge to Lescol by Novartis (SmartBrief) Levaquin (Levofloxacin) - UK: Levofloxacin SPC valid: Generics (UK) Ltd v Daiichi Pharmaceutical Co Ltd & Anor… [read post]
10 Jul 2008, 5:31 pm
Nov. 6, 2000 & July 9, 2001).Texas: Ethicon Endo-Surgery, Inc. v. [read post]
23 Dec 2013, 5:16 am
Pfizer, Inc., 712 F.3d 21 (1st Cir. 2013), Aetna, Inc. v. [read post]
16 Jun 2010, 3:02 pm
Zydus Pharmaceuticals USA, Inc. et al. [read post]
27 Feb 2009, 5:00 am
Teva Parenteral Medicines Inc. et al. [read post]
8 Aug 2012, 8:03 am
Companies involved include Bard, Boston Scientific Group, American Medical Systems and Endo Pharmaceutical Holdings, Inc. [read post]
22 Mar 2011, 4:21 pm
General New IP resource for Pharma, Biotech and Chem – Compulsory licences, comparing national requirements (IP Think Tank) WIPO and India partner to protect traditional knowledge from misappropriation (WIPO) UN Rapporteur for the Right to Health asked to intervene in the TPP negotiation (KEI) Patents and doctors, and the USTR TPP text (KEI) Biotech industry losing interest in the therapeutic potential of RNAi (Patent Docs) India: The curious case of the ‘data exclusivity’ volte… [read post]
30 Jul 2021, 7:01 am
The New York State opioid trial continues against three major drugmakers, Endo International Plc., Teva Pharmaceutical Industries Ltd., and AbbVie Inc’s Allergan unit, which all stand accused of having deceptively marketed their opioid painkillers. [read post]
5 Jul 2007, 10:37 am
App. 1974).Texas: Ethicon Endo-Surgery, Inc. v. [read post]
24 Aug 2011, 12:33 am
The lobbying push for a PTE (FDA Law Blog) US: Generics fees: A fantastic opportunity (profitability through simplicity) USPTO announces agenda for next BCP customer partnership meeting (Patent Docs) US: GOP candidates unified in opposition to embryonic cell research (Patent Docs) US: District Court Massachusetts: Method of detecting fetal down syndrome passes muster under Bilski‘s machine-or-transformation test: PerkinElmer, Inc., et. al. v. [read post]
8 Aug 2012, 8:30 pm
(BSX), Murray Hill, Johnson & Johnson (JNJ), Endo Pharmaceutical Holdings Inc., and other companies. [read post]
25 Apr 2011, 3:24 am
(PFE), Johnson & Johnson (JNJ) and Endo Pharmaceuticals Holdings Inc. [read post]
25 Apr 2011, 3:19 am
(PFE), Johnson & Johnson (JNJ) and Endo Pharmaceuticals Holdings Inc. [read post]
3 Jun 2016, 6:40 am
Momenta Pharmaceuticals, Inc., et al., No. 15-1402 (scope of 271(e) safe harbor) Exhaustion: Impression Products, Inc. v. [read post]
